Skinvisible (SKVI) Current Assets (2010 - 2026)
Skinvisible's (SKVI) quarterly Current Assets came in at $33301.0 in Q2 2026, up 0.6% year-over-year from $33102.0 in Q2 2025, and up 36.54% quarter-over-quarter from $24390.0 in Q1 2026.
Powered by 
Analysis
Skinvisible (SKVI) Current Assets (2010 - 2026) Analysis & Trends
Skinvisible has disclosed Current Assets across 17 years of filings, most recently posting $33301.0 for Q2 2026.
- In Q2 2026, Current Assets rose 0.6% year-over-year to $33301.0; the TTM figure through Jun 2026 stood at $33301.0 (up 0.6% YoY), while the FY2025 annual figure was $27531.0, down 34.49% from the prior year.
- Current Assets came in at $33301.0 for Q2 2026 at Skinvisible, up from $24390.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $174801.0 in Q2 2022 to a low of $24390.0 in Q1 2026.
- Average Current Assets over 5 years is $55566.1, with a median of $35671.0 recorded in 2023.
- Year-over-year, Current Assets surged 155.74% in 2022 and slumped 67.75% in 2023.
- Over 5 years, Current Assets stood at $109946.0 in 2022, then tumbled by 67.75% to $35460.0 in 2023, then climbed by 18.52% to $42028.0 in 2024, then plunged by 34.49% to $27531.0 in 2025, then grew by 20.96% to $33301.0 in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $33301.0 in Q2 2026, $24390.0 in Q1 2026, and $27531.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 41.36 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 36.64 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 4.03 Bn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 6.03 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 3.48 Bn |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | 33,301.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33,301.00 |
| Mar 31, 2026 | 24,390.00 |
| Dec 31, 2025 | 27,531.00 |
| Sep 30, 2025 | 28,469.00 |
| Jun 30, 2025 | 33,102.00 |
| Mar 31, 2025 | 38,305.00 |
| Dec 31, 2024 | 42,028.00 |
| Sep 30, 2024 | 27,404.00 |
| Jun 30, 2024 | 35,882.00 |
| Mar 31, 2024 | 30,689.00 |
| Dec 31, 2023 | 35,460.00 |
| Sep 30, 2023 | 52,905.00 |
| Jun 30, 2023 | 59,622.00 |
| Mar 31, 2023 | 73,130.00 |
| Dec 31, 2022 | 109,946.00 |
| Sep 30, 2022 | 138,098.00 |
| Jun 30, 2022 | 174,801.00 |
| Mar 31, 2022 | 35,126.00 |
| Dec 31, 2021 | 74,244.00 |
| Sep 30, 2021 | 58,021.00 |